These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 9594927)
1. Lipid altering or antioxidant vitamins for patients with coronary disease and very low HDL cholesterol? The HDL-Atherosclerosis Treatment Study Design. Brown BG; Zhao XQ; Chait A; Frohlich J; Cheung M; Heise N; Dowdy A; DeAngelis D; Fisher LD; Albers J Can J Cardiol; 1998 Apr; 14 Suppl A():6A-13A. PubMed ID: 9594927 [TBL] [Abstract][Full Text] [Related]
2. Safety and tolerability of simvastatin plus niacin in patients with coronary artery disease and low high-density lipoprotein cholesterol (The HDL Atherosclerosis Treatment Study). Zhao XQ; Morse JS; Dowdy AA; Heise N; DeAngelis D; Frohlich J; Chait A; Albers JJ; Brown BG Am J Cardiol; 2004 Feb; 93(3):307-12. PubMed ID: 14759379 [TBL] [Abstract][Full Text] [Related]
3. Lipid-altering efficacy and safety of ezetimibe/simvastatin coadministered with extended-release niacin in patients with type IIa or type IIb hyperlipidemia. Guyton JR; Brown BG; Fazio S; Polis A; Tomassini JE; Tershakovec AM J Am Coll Cardiol; 2008 Apr; 51(16):1564-72. PubMed ID: 18420099 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of combination of extended release niacin and atorvastatin in patients with low levels of high density lipoprotein cholesterol. Harikrishnan S; Rajeev E; Tharakan JA; Titus T; Ajit Kumar VK; Sivasankaran S; Krishnamoorthy KM; Nair K Indian Heart J; 2008; 60(3):215-22. PubMed ID: 19240310 [TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein modifying effects of statins and fibrate in various age groups of coronary artery disease patients. Sharma R; Mahajan M; Singh B; Bal BS; Kant R J Indian Med Assoc; 2006 Sep; 104(9):492-4, 496, 498. PubMed ID: 17388006 [TBL] [Abstract][Full Text] [Related]
6. Niacin-based therapy for dyslipidemia: past evidence and future advances. Ito MK Am J Manag Care; 2002 Sep; 8(12 Suppl):S315-22. PubMed ID: 12240703 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the safety and efficacy of a combination tablet of niacin extended release and simvastatin vs simvastatin monotherapy in patients with increased non-HDL cholesterol (from the SEACOAST I study). Ballantyne CM; Davidson MH; McKenney J; Keller LH; Bajorunas DR; Karas RH Am J Cardiol; 2008 May; 101(10):1428-36. PubMed ID: 18471454 [TBL] [Abstract][Full Text] [Related]
8. Antioxidant versus lipid-altering therapy--some answers, more questions. Freedman JE N Engl J Med; 2001 Nov; 345(22):1636-7. PubMed ID: 11757512 [No Abstract] [Full Text] [Related]
9. Efficacy and safety of high-density lipoprotein cholesterol-increasing compounds: a meta-analysis of randomized controlled trials. Birjmohun RS; Hutten BA; Kastelein JJ; Stroes ES J Am Coll Cardiol; 2005 Jan; 45(2):185-97. PubMed ID: 15653014 [TBL] [Abstract][Full Text] [Related]
10. Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: the role of nicotinic acid--a position paper developed by the European Consensus Panel on HDL-C. Chapman MJ; Assmann G; Fruchart JC; Shepherd J; Sirtori C; Curr Med Res Opin; 2004 Aug; 20(8):1253-68. PubMed ID: 15324528 [TBL] [Abstract][Full Text] [Related]
11. Dyslipidaemia in diabetic patients: time for a rethink. Shepherd J Diabetes Obes Metab; 2007 Sep; 9(5):609-16. PubMed ID: 17697054 [TBL] [Abstract][Full Text] [Related]
12. Targeting cardiovascular risk associated with both low density and high density lipoproteins using statin-niacin combination therapy. Duvall WL; Blazing MA; Saxena S; Guyton JR J Cardiovasc Risk; 2002 Dec; 9(6):339-47. PubMed ID: 12478203 [TBL] [Abstract][Full Text] [Related]
13. Safety of niacin and simvastatin combination therapy. Bays H Am J Cardiol; 2008 Apr; 101(8A):3B-8B. PubMed ID: 18375239 [TBL] [Abstract][Full Text] [Related]
14. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. Brown BG; Zhao XQ; Chait A; Fisher LD; Cheung MC; Morse JS; Dowdy AA; Marino EK; Bolson EL; Alaupovic P; Frohlich J; Albers JJ N Engl J Med; 2001 Nov; 345(22):1583-92. PubMed ID: 11757504 [TBL] [Abstract][Full Text] [Related]
15. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial). Goldenberg I; Benderly M; Sidi R; Boyko V; Tenenbaum A; Tanne D; Behar S Am J Cardiol; 2009 Jan; 103(1):41-5. PubMed ID: 19101227 [TBL] [Abstract][Full Text] [Related]
16. Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment. Ansell BJ; Navab M; Hama S; Kamranpour N; Fonarow G; Hough G; Rahmani S; Mottahedeh R; Dave R; Reddy ST; Fogelman AM Circulation; 2003 Dec; 108(22):2751-6. PubMed ID: 14638544 [TBL] [Abstract][Full Text] [Related]
17. Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial. Jones PH; Hunninghake DB; Ferdinand KC; Stein EA; Gold A; Caplan RJ; Blasetto JW; Clin Ther; 2004 Sep; 26(9):1388-99. PubMed ID: 15531001 [TBL] [Abstract][Full Text] [Related]
18. Tolerability and effects on lipids of ezetimibe coadministered with pravastatin or simvastatin for twelve months: results from two open-label extension studies in hypercholesterolemic patients. Strony J; Hoffman R; Hanson M; Veltri E Clin Ther; 2008 Dec; 30(12):2280-97. PubMed ID: 19167588 [TBL] [Abstract][Full Text] [Related]
19. Prevention of coronary atherosclerosis by the use of combination therapy with antioxidant coenzyme Q10 and statins. Chapidze G; Kapanadze S; Dolidze N; Bachutashvili Z; Latsabidze N Georgian Med News; 2005 Jan; (118):20-5. PubMed ID: 15821319 [TBL] [Abstract][Full Text] [Related]